Infection and Drug Resistance · 2020 · 17 citations · 14 references
MedicineHematologyMicrobiologyChemotherapyHematologic OncologyMedical MicrobiologyAntibacterial TherapyAntibiotic ResistanceAntimicrobial TherapyBacterial InfectionsEmpiric Antimicrobial TherapyFebrile Neutropenia ManagementAcute Leukemia ChemotherapyChemotherapy-associated InfectionFebrile Neutropenia Empiric TherapyFebrile Neutropenia TreatmentGram-negative Bacterial InfectionsInappropriate Antibiotic Use
Background: The epidemiology of Gram-negative bacteria in patients with febrile neutropenia (FN) and their susceptibility to initial empirical antibiotic therapy is key to successful treatment during the treatment of hematologic malignancies. Methods: A retrospective study was conducted. Patients with FN and confirmed laboratory results of Gram-negative bacteria infections were included. If no direct sensitivity of the identified pathogen to the initially prescribed antibiotic regimen was confirmed, it was defined as inappropriate initial antibiotic treatment (IIAT). Results: A total of 247 patients with FN were proven to be infected with Gram-negative bacteria, and 200 were diagnosed with acute leukemia. The most commonly detected bacteria were Escherichia coli (40%), Klebsiella pneumoniae (20%), and Pseudomonas aeruginosa (11%). In sum, 176 patients were classified as IIAT. The mortality rate in the IIAT group was significantly higher (37.7% vs 23.9%, P =0.038). With monotherapy as empirical treatment, high possibility of IIAT with fluoroquinolones (52%) and cephalosporins (35%) was detected, while more sensitivity to carbapenems (16%) and glycopeptides antibiotics (19%) was noticed. With combined treatment, cephalosporins/carbapenems had with the lowest percentage of IIAT (18%). Conclusion: In conclusion, inappropriate initial empirical antibiotic treatments were associated with higher mortality in patients with hematologic malignancies. The current empirical antibiotic regimen needs to be further optimized. Keywords: febrile neutropenia, Gram-negative bacteria, hematologic malignancy, empirical antibiotic treatment, inappropriate initial antibiotic treatment
14
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Nicole M. Kuderer, David C. Dale, Jeffrey Crawford et al. · Cancer · 2006 · 1.2K citations · Full text
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
Jean Klášterský, Julien de Naurois, K. V. I. Rolston et al. · Annals of Oncology · 2016 · 750 citations · Full text
Alessandra Micozzi, Giuseppe Gentile, Clara Minotti et al. · BMC Infectious Diseases · 2017 · 111 citations · Full text
Jason R. Conn, Elizabeth Catchpoole, Naomi Runnegar et al. · PLoS ONE · 2017 · 100 citations · Full text